UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000053847 |
|---|---|
| Receipt number | R000061455 |
| Scientific Title | Research for the relationship between blood glucose levels and pulse-waves in the palmar artery |
| Date of disclosure of the study information | 2024/03/14 |
| Last modified on | 2024/04/04 12:57:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Research for the relationship between blood glucose levels and pulse-waves in the palmar artery
Acronym
Research for the relationship between blood glucose levels and pulse-waves in the palmar artery
Scientific Title
Research for the relationship between blood glucose levels and pulse-waves in the palmar artery
Scientific Title:Acronym
Research for the relationship between blood glucose levels and pulse-waves in the palmar artery
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of the study is to collect data to clarify the relationship between blood glucose levels and pulse-waves, derive the relationship between blood glucose levels and pulse-waves, and establish technology to estimate the state of glucose metabolism (blood glucose levels, etc.) from pulse-waves using machine learning and other methods.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Relationship between blood glucose levels and pulse-waves.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 35 | years-old | <= |
Age-upper limit
| 74 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Persons who have good health (those who have no past history of chronic diseases or malignant tumors and are not under treatment for diseases or injuries)
2. Persons who do not take medications. (Medications that affect blood vessel stiffness)
3. Non-smokers
4. Japanese
Key exclusion criteria
1. Persons who were judged as inappropriate for study participants by the principal investigator
Target sample size
268
Research contact person
Name of lead principal investigator
| 1st name | Shiro |
| Middle name | |
| Last name | MINAMI |
Organization
SunMarco Clinic
Division name
-
Zip code
211-0004
Address
2F, 1-825-7, Sinmarukohigashi, Nakahara-ku, Kawasaki, Kanagawa, JAPAN
TEL
044-433-3005
shirom@sunmarcocl.com
Public contact
Name of contact person
| 1st name | Takafumi |
| Middle name | |
| Last name | TAKAGI |
Organization
KYOCERA Corporation
Division name
Medical R&D Center
Zip code
220-0012
Address
3-7-1, Minatomirai, Nishi-ku, Yokohama, Kanagawa, JAPAN
TEL
045-605-7090
Homepage URL
takafumi.takagi.cy@kyocera.jp
Sponsor or person
Institute
KYOCERA Corporation
Institute
Department
Personal name
Funding Source
Organization
KYOCERA Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Macromill, Inc.
Healthcare Systems Co., Ltd.
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Ethics Committee of Healthcare Systems Co., Ltd.
Address
1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN
Tel
03-6809-2722
soumu@hc-sys.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 03 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
268
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 02 | Month | 13 | Day |
Date of IRB
| 2024 | Year | 02 | Month | 13 | Day |
Anticipated trial start date
| 2024 | Year | 03 | Month | 15 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2024 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
Clarify the relationship between blood glucose levels and pulse-waves.
Management information
Registered date
| 2024 | Year | 03 | Month | 13 | Day |
Last modified on
| 2024 | Year | 04 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061455
